Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €11.66 EUR
Change Today +0.159 / 1.38%
Volume 416.0
GME On Other Exchanges
As of 1:55 PM 10/2/15 All times are local (Market data is delayed by at least 15 minutes).

geratherm medical ag (GME) Snapshot

Previous Close
Day High
Day Low
52 Week High
05/29/15 - €13.48
52 Week Low
10/15/14 - €6.89
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for GERATHERM MEDICAL AG (GME)

Related News

No related news articles were found.

geratherm medical ag (GME) Related Businessweek News

No Related Businessweek News Found

geratherm medical ag (GME) Details

Geratherm Medical AG, a medical technology company, engages in the healthcare diagnostic, respiratory, medical warning system, and cardio/stroke businesses in Europe, South America, Germany, the Middle East, the United States, and internationally. It operates through Healthcare Diagnostic, Warming Systems, Cardio/Stroke, and Respiratory segments. The Healthcare Diagnostic segment offers clinical thermometers; blood pressure monitors; and products for women comprising pregnancy tests, various ovulation tests, chlamydia tests, yeast infection test kits, and pH tests. The Warming Systems segment provides medical warming systems under the UniqueTemp and Unique Resc+ brand names to maintain body temperature during operations and in rescue situations; and normac IC, an incubatory system offers solutions for premature newborns with its MR diagnostic. The Cardio/Stroke segment offers stroke risk analyser products consists of SRAclinic for dectecting paroxysmal atrial fibrillation to prevent strokes. The Respiratory segment is involved in the development and manufacture of Spirostik, Spirostik Complete, and spiroergometer for pulmonary and cardiopulmonary function diagnostics. The company markets its products through pharmacies, hospitals, and clinics. It exports its products to approximately 60 countries. Geratherm Medical AG is headquartered in Geschwenda, Germany.

142 Employees
Last Reported Date: 08/20/15

geratherm medical ag (GME) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

geratherm medical ag (GME) Key Developments

Geratherm Medical AG - Shareholder/Analyst Call

Geratherm Medical AG - Shareholder/Analyst Call

Geratherm Medical AG to Report Q2, 2015 Results on Aug 20, 2015

Geratherm Medical AG announced that they will report Q2, 2015 results on Aug 20, 2015

Geratherm Medical AG Presents at 13th SCC Small Cap Conference, Aug-31-2015 05:20 PM

Geratherm Medical AG Presents at 13th SCC Small Cap Conference, Aug-31-2015 05:20 PM. Venue: DVFA Center, Mainzer Landstr. 37-039, 60329 Frankfurt am Main, Germany. Speakers: Gert Michael Frank, Chairman of Management Board, Chief Executive Officer and Chairman of Executive Committee.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GME:GR €11.66 EUR +0.159

GME Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for GME.
View Industry Companies

Industry Analysis


Industry Average

Valuation GME Industry Range
Price/Earnings 28.4x
Price/Sales 2.8x
Price/Book 2.8x
Price/Cash Flow 20.0x
TEV/Sales 2.0x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GERATHERM MEDICAL AG, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at